Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. - Wikidata - wikimedia - TriplyDB

Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation.

Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation.

http://www.wikidata.org/entity/Q37047884

about

Macrophage functions in lean and obese adipose tissue.The impact of bariatric surgery on inflammation: quenching the fire of obesity?The initiation of metabolic inflammation in childhood obesity.The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.Weight Management in Patients with Type 1 Diabetes and Obesity.Circulating sex steroids coregulate adipose tissue immune cell populations in healthy men.Macrophage Area Content and Phenotype in Hepatic and Adipose Tissue in Patients with Obesity Undergoing Roux-en-Y Gastric Bypass.Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass

P2860

Q36412774-F4D073DE-562B-4E51-9108-EAD4E60FEEE7 Q38838093-55D7F75C-F6BE-408B-B4CB-FB47EDCDCA40 Q39065628-F3768279-C913-44C8-821F-8EABD04ED5EE Q40245292-308847CB-49D0-4EB0-A590-090DBC4A6D14 Q41504692-2810614C-4FEB-4C7E-B641-5139C0F10BE1 Q46073601-482F63F8-EA5B-4D33-A18C-9F87C6121B8D Q48331290-A57CD713-2408-434D-81BF-E46DE277861E Q57108626-65D4A058-CB04-4EB6-A634-A0CCC20E0290

P2860

Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation.

http://www.wikidata.org/entity/Q37047884

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improvements in glycemic contr ...... t adipose tissue inflammation.

@en

Improvements in glycemic contr ...... t adipose tissue inflammation.

@nl

type

label

Improvements in glycemic contr ...... t adipose tissue inflammation.

@en

Improvements in glycemic contr ...... t adipose tissue inflammation.

@nl

prefLabel

Improvements in glycemic contr ...... t adipose tissue inflammation.

@en

Improvements in glycemic contr ...... t adipose tissue inflammation.

@nl

P1433

Q37047884-C84F61BA-2FF1-4FAF-9764-7570A0A719D5

P1476

Q37047884-563426BF-1A4A-4F35-9E0D-23ABC92E53AC

P2093

Q37047884-19BBACA9-AD0C-4416-8039-757AF34ABE0F

Q37047884-23B903F0-154F-464E-8C49-40D2303F2165

Q37047884-56E006B6-96E2-4295-BBEC-6159A009681F

Q37047884-5EAE9C4D-6D93-4770-9227-5EF11829FA35

Q37047884-828A19E0-7868-44FB-B09F-31BD7FA86BAC

Q37047884-A6200D1F-2F48-4698-B118-3C22ACF27E07

Q37047884-D232E9F5-ECE2-429F-BCCB-CAEA36C8382E

Q37047884-E22B0585-C146-4F51-82AA-1694B59A835D

Q37047884-ECBD0792-1C9B-421F-9071-528EA4945D35

Q37047884-F6CA0C26-1D58-4EB5-98C9-023ED149C918

P2860

Q37047884-01A20953-0633-4B14-9681-C2AADA95378E

Q37047884-1C5C0C66-B2BF-4CE3-BAE5-02EC6797A43B

Q37047884-23980382-8706-4978-A6A8-6757B7BEEA43

Q37047884-25DA9F9B-525A-498D-9140-0C44B9C59794

Q37047884-36C94613-DBAB-4451-81CB-4BF3A847828C

Q37047884-38434504-2773-4861-A298-000073FC1C81

Q37047884-3AF8FC78-6953-42EF-8823-4AAB941467FF

Q37047884-429362B5-B481-4417-A8F2-5B1FF71F5C56

Q37047884-458EA38F-D887-4F1C-8C77-F3CDA7C2EBEF

Q37047884-5010EAB9-3B5E-40D6-A67B-4527F534A3E3

P304

Q37047884-1F09BE75-9CB7-4019-A067-722C5E91D3BA

P31

Q37047884-6EE0C5D3-C8AB-4F0B-AE53-1996941230B5

P356

Q37047884-661D5D05-17FC-4168-B227-1457DCC03D46

P433

Q37047884-5DD125D2-58D0-4BDF-87EF-8375546D4C86

P478

Q37047884-7A9FBAE6-5336-4793-A78D-A7BFFB11240B

P577

Q37047884-99411208-D834-4F6E-8B8B-6C7355D1C6BF

P698

Q37047884-E16FD2E2-8D89-43B8-8B8D-377F7B5E47BF

P921

Q37047884-E9871389-9505-4DF8-A891-519D5F5B5519

P932

Q37047884-1A559FC1-78FB-4E0B-B7E9-EAFCF4A96A91

P356

P1433

P1476

Improvements in glycemic contr ...... t adipose tissue inflammation.

@en

P2093

Brian van Yserloo

http://www.w3.org/2001/XMLSchema#string

Chun P Chan

http://www.w3.org/2001/XMLSchema#string

David E Arterburn

http://www.w3.org/2001/XMLSchema#string

David E Cummings

http://www.w3.org/2001/XMLSchema#string

David R Flum

http://www.w3.org/2001/XMLSchema#string

Derek K Hagman

http://www.w3.org/2001/XMLSchema#string

Emily O Westbrook

http://www.w3.org/2001/XMLSchema#string

Jessica N Kuzma

http://www.w3.org/2001/XMLSchema#string

Karen E Foster-Schubert

http://www.w3.org/2001/XMLSchema#string

Mario Kratz

http://www.w3.org/2001/XMLSchema#string

P2860

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

Inflammation and metabolic disorders

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

IKK-beta links inflammation to obesity-induced insulin resistance

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.

Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy.

P304

1438-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/OBY.21524

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27228052

http://www.w3.org/2001/XMLSchema#string

P921

P932

4925247

http://www.w3.org/2001/XMLSchema#string